Analyst Comment
Aiforia’s partner network expands to Canada
Translation: Original published in Finnish on 03/18/2025 at 10:23 am EET
The company today announced a partnership with the Canadian Quorum Technologies. Based on the announcement, Quorum will act as an integrator in the implementation of Aiforia’s solution and support sales.
The partner channel is important for the company, as building own direct sales in all markets would not, in our view, be practical or financially sensible as the market is forming rapidly. Utilizing integrators also allows Aiforia to ramp up more customers simultaneously.
New partnerships are naturally positive for Aiforia, as they reflect the attractiveness of the company's image analysis solutions in the digital pathology market and improve the prerequisites for winning new customers. Our estimates expect the company to successfully implement its growth strategy, including continuous customer wins and accelerating revenue growth, so the release does not affect our view of the company.
Aiforia Technologies equips pathologists and researchers in preclinical and clinical laboratories with software to translate images into discoveries, decisions and diagnoses. The company's products and services are used for medical image analysis, across a variety of fields such as oncology and neuroscience. Aiforia Technologies is headquartered in Finland.
Read more on company pageKey Estimate Figures10.03.2025
| 2024 | 25e | 26e | |
|---|---|---|---|
| Revenue | 2.9 | 4.7 | 7.6 |
| growth-% | 18.9 % | 65.7 % | 60.0 % |
| EBIT (adj.) | -12.2 | -11.9 | -12.0 |
| EBIT-% (adj.) | -427.8 % | -252.9 % | -158.1 % |
| EPS (adj.) | -0.41 | -0.36 | -0.36 |
| Dividend | 0.00 | 0.00 | 0.00 |
| Dividend % | |||
| P/E (adj.) | neg. | neg. | neg. |
| EV/EBITDA | neg. | neg. | neg. |
Forum discussions
